- Home
- AMPX vs RZLT Comparison
AMPX vs RZLT Comparison
Compare AMPX & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPX
- RZLT
- Stock Information
- Founded
- AMPX 2008
- RZLT 2010
- Country
- AMPX United States
- RZLT United States
- Employees
- AMPX N/A
- RZLT N/A
- Industry
- AMPX Industrial Machinery/Components
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- AMPX Miscellaneous
- RZLT Health Care
- Exchange
- AMPX Nasdaq
- RZLT Nasdaq
- Market Cap
- AMPX 261.0M
- RZLT 283.3M
- IPO Year
- AMPX N/A
- RZLT N/A
- Fundamental
- Price
- AMPX $3.01
- RZLT $4.53
- Analyst Decision
- AMPX Strong Buy
- RZLT Strong Buy
- Analyst Count
- AMPX 8
- RZLT 8
- Target Price
- AMPX $8.63
- RZLT $12.00
- AVG Volume (30 Days)
- AMPX 3.0M
- RZLT 419.2K
- Earning Date
- AMPX 03-20-2025
- RZLT 02-12-2025
- Dividend Yield
- AMPX N/A
- RZLT N/A
- EPS Growth
- AMPX N/A
- RZLT N/A
- EPS
- AMPX N/A
- RZLT N/A
- Revenue
- AMPX $17,480,000.00
- RZLT N/A
- Revenue This Year
- AMPX $132.63
- RZLT N/A
- Revenue Next Year
- AMPX $214.27
- RZLT N/A
- P/E Ratio
- AMPX N/A
- RZLT N/A
- Revenue Growth
- AMPX 196.22
- RZLT N/A
- 52 Week Low
- AMPX $0.61
- RZLT $1.57
- 52 Week High
- AMPX $4.21
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- AMPX 43.80
- RZLT 41.29
- Support Level
- AMPX $3.28
- RZLT $4.50
- Resistance Level
- AMPX $3.65
- RZLT $5.28
- Average True Range (ATR)
- AMPX 0.28
- RZLT 0.36
- MACD
- AMPX -0.06
- RZLT -0.06
- Stochastic Oscillator
- AMPX 8.49
- RZLT 4.03
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high energy density lithium-ion batteries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. All of its revenues is geographically earned in the United States.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.